Related Experiment Video
Updated: Mar 10, 2026

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
Published on: June 27, 2025
Discharge Disposition After Stroke in Patients With Liver Disease
Neal S Parikh1, Alexander E Merkler2, Yecheskel Schneider2
1From the Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute (N.S.P., A.E.M., B.B.N., H.K.), Department of Neurology (N.S.P., A.E.M., B.B.N., H.K.), and Division of Gastroenterology and Hepatology (Y.S.), Weill Cornell Medicine, New York, NY. nsp2001@nyp.org.
Insights
Patients with liver disease face worse outcomes after stroke, including poorer discharge disposition and higher in-hospital mortality rates for both hemorrhagic and ischemic stroke types.
Area of Science:
- Neurology
- Hepatology
- Public Health
Background:
- Liver disease is linked to bleeding and clotting issues, increasing intracranial hemorrhage risk.
- Understanding liver disease impact on stroke outcomes is crucial for patient care.
Purpose of the Study:
- To assess the association between liver disease and stroke outcomes, specifically discharge disposition.
- To analyze the impact of liver disease on in-hospital mortality following stroke.
Main Methods:
- Utilized administrative claims data from California, Florida, and New York (2005-2013).
- Identified patients hospitalized with stroke, with liver disease as the predictor variable.
- Employed ordinal and logistic regression, adjusting for demographics, vascular risk factors, and comorbidities.
Main Results:
- Liver disease was present in 1.7% of over 825,000 stroke patients.
- Liver disease correlated with worse discharge disposition for both intracerebral hemorrhage (OR 1.28) and ischemic stroke (OR 1.23).
- Liver disease significantly increased in-hospital mortality risk for intracerebral hemorrhage (OR 1.33) and ischemic stroke (OR 1.60).
Conclusions:
- Liver disease is associated with adverse hospital discharge outcomes post-stroke.
- The findings suggest poorer functional outcomes for stroke patients with liver disease.
- Liver disease presence indicates a higher risk of in-hospital mortality after stroke.
Background And Purpose:
Liver disease is associated with both hemorrhagic and thrombotic processes, including an elevated risk of intracranial hemorrhage. We sought to assess the relationship between liver disease and outcomes after stroke, as measured by discharge disposition.
Methods:
Using administrative claims data, we identified a cohort of patients hospitalized with stroke in California, Florida, and New York from 2005 to 2013. The predictor variable was liver disease. All diagnoses were defined using validated diagnosis codes. Ordinal logistic regression was used to analyze the association between liver disease and worsening discharge disposition: home, nursing/rehabilitation facility, or death. Secondarily, multiple logistic regression was used to analyze the association between liver disease and in-hospital mortality. Models were adjusted for demographics, vascular risk factors, and comorbidities.
Results:
We identified 121 428 patients with intracerebral hemorrhage and 703 918 with ischemic stroke. Liver disease was documented in 13 584 patients (1.7%). Liver disease was associated with worse discharge disposition after both intracerebral hemorrhage (global odds ratio, 1.28; 95% confidence interval, 1.19-1.38) and ischemic stroke (odds ratio, 1.23; 95% confidence interval, 1.17-1.29). Similarly, liver disease was associated with in-hospital death after both intracerebral hemorrhage (odds ratio, 1.33; 95% confidence interval, 1.23-1.44) and ischemic stroke (odds ratio, 1.60; 95% confidence interval, 1.51-1.71).
Conclusions:
Liver disease was associated with worse hospital discharge disposition and in-hospital mortality after stroke, suggesting worse functional outcomes.
More Related Videos
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Venous Thrombosis IV: Nursing Management

